Olema Pharmaceuticals Inc

NASDAQ:OLMA   4:00:00 PM EDT
2.49
-0.30 (-10.75%)
4:24:12 PM EDT: $2.49 0.00 (0.00%)
Earnings Announcements

Olema Oncology Reports Third Quarter 2022 Financial Results

Published: 11/08/2022 21:58 GMT
Olema Pharmaceuticals Inc (OLMA) - Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Cash, Cash Equivalents and Marketable Securities Position of $222.6 Million As of September 30, 2022.
Qtrly Loss per Share $0.57.
Q3 Earnings per Share View $-0.77 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.